$3.99
+0.09 (+2.31%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+426.3% upside
Low Target
$13.91
Average Target
$21.00
High Target
$28.26
Current Price
$3.99
Current
$3.99
$3.99
Target
$21.00
$21.00
$13.91
$21.00 avg
$28.26
Scenario Analysis
Bear Case
$13.91
248.6%
Low target
Base Case
$21.00
+426.3%
Avg target
Bull Case
$28.26
+608.3%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$5.38
-25.8% from high
52-Week Low
$2.19
+82.6% from low
Target vs 52W High
$21.00
+290.3% vs high
Next Earnings Report
Aug 18, 2026
2d
until earnings
EPS Est: $-0.55
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |